A detailed history of Gamma Investing LLC transactions in Galapagos Nv stock. As of the latest transaction made, Gamma Investing LLC holds 1,259 shares of GLPG stock, worth $33,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,259
Previous 523 140.73%
Holding current value
$33,741
Previous $13 Million 179.68%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$24.2 - $30.67 $17,811 - $22,573
736 Added 140.73%
1,259 $36.2 Million
Q2 2024

Jul 02, 2024

SELL
$24.78 - $32.48 $6,244 - $8,184
-252 Reduced 32.52%
523 $13 Million
Q1 2024

Apr 05, 2024

SELL
$32.2 - $42.44 $12,429 - $16,381
-386 Reduced 33.25%
775 $25 Million
Q4 2023

Feb 01, 2024

BUY
$31.87 - $40.71 $37,001 - $47,264
1,161 New
1,161 $43.6 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.76B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.